Fridge-free vaccines could prompt Africa immunization breakthrough

Vaccines that can be stored without refrigeration have shown promise in clinical trials, potentially revolutionizing immunization efforts in Africa. According to the World Health Organization, one in five children in Africa remains unvaccinated. This breakthrough stems from a trial conducted by British pharmaceutical company Stablepharma, whose technology utilizes a sugar called trehalose to transform vaccines into a powdered form.

This powdered vaccine can be stored at room temperature and later reconstituted with water for administration. The conventional refrigeration requirement for most vaccines, including the tetanus-diphtheria jab used in the trial, often leads to a significant loss of potency due to disruptions in the "cold chain" during production, transport, and delivery.

By eliminating the need for refrigeration, this innovative approach could greatly reduce vaccine wastage, currently estimated at around half of all vaccines annually. The successful completion of a larger trial is expected to pave the way for potential widespread implementation, addressing a critical gap in Africa's immunization coverage.